UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 3.805

Sortiert nach

Sodium-glucose cotransporter 2 inhibitors (SGLT2i) and cardiac arrhythmias: a systematic review and meta-analysis

Cardiovascular diabetology, 2021-05, Vol.20 (1), p.100-100, Article 100

2021

Volltextzugriff (PDF)

Inflammation in Atrial Fibrillation

Journal of the American College of Cardiology, 2012-12, Vol.60 (22), p.2263-2270

2012

Volltextzugriff (PDF)

New Oral Anticoagulants in Elderly Adults: Evidence from a Meta-Analysis of Randomized Trials

Journal of the American Geriatrics Society (JAGS), 2014-05, Vol.62 (5), p.857-864

2014

Volltextzugriff (PDF)

Stroke prevention in atrial fibrillation: an Asian perspective

Thrombosis and haemostasis, 2014, Vol.111 (5), p.789

2014

Volltextzugriff (PDF)

The Role of Monocytes in Angiogenesis and Atherosclerosis

Journal of the American College of Cardiology, 2014, Vol.63 (1), p.1-11

2014

Volltextzugriff (PDF)

Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited

The Lancet (British edition), 2009-01, Vol.373 (9658), p.155-166

2009

Volltextzugriff (PDF)

Comparative Validation of a Novel Risk Score for Predicting Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation: The HAS-BLED (Hypertension, Abnormal Renal/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly, Drugs/Alcohol Concomitantly) Score

Journal of the American College of Cardiology, 2011-01, Vol.57 (2), p.173-180

2011

Volltextzugriff (PDF)

Stroke and Bleeding in Atrial Fibrillation with Chronic Kidney Disease

The New England journal of medicine, 2012-08, Vol.367 (7), p.625-635

2012

Volltextzugriff (PDF)

Lipids and atrial fibrillation: New insights into a paradox

PLoS medicine, 2022-08, Vol.19 (8), p.e1004067-e1004067

2022

Volltextzugriff (PDF)

Discontinuation risk comparison among 'real-world' newly anticoagulated atrial fibrillation patients: Apixaban, warfarin, dabigatran, or rivaroxaban

PloS one, 2018-04, Vol.13 (4), p.e0195950-e0195950

2018

Volltextzugriff (PDF)

Invited review: hypertension and atrial fibrillation: epidemiology, pathophysiology, and implications for management

Journal of human hypertension, 2019-12, Vol.33 (12), p.824-836

2019

Volltextzugriff (PDF)

EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: definition, characterization, and clinical implication

Europace (London, England), 2016-10, Vol.18 (10), p.1455-1490

2016

Volltextzugriff (PDF)

Net Clinical Benefit of Antithrombotic Therapy in Patients With Atrial Fibrillation and Chronic Kidney Disease: A Nationwide Observational Cohort Study

Journal of the American College of Cardiology, 2014-12, Vol.64 (23), p.2471-2482

2014

Volltextzugriff (PDF)

Hypertension management in cardio-oncology

Journal of human hypertension, 2020-10, Vol.34 (10), p.673-681

2020

Volltextzugriff (PDF)

Underuse of Oral Anticoagulants in Atrial Fibrillation: A Systematic Review

The American journal of medicine, 2010-07, Vol.123 (7), p.638-645.e4

2010

Volltextzugriff (PDF)

Temporal trends of antithrombotic therapy for stroke prevention in Korean patients with non-valvular atrial fibrillation in the era of non-vitamin K antagonist oral anticoagulants: A nationwide population-based study

PloS one, 2017-12, Vol.12 (12), p.e0189495-e0189495

2017

Volltextzugriff (PDF)

Causes of death of patients with non-valvular atrial fibrillation in Asians

PloS one, 2023-03, Vol.18 (3), p.e0282455-e0282455

2023

Volltextzugriff (PDF)

Indirect Comparisons of New Oral Anticoagulant Drugs for Efficacy and Safety When Used for Stroke Prevention in Atrial Fibrillation

Journal of the American College of Cardiology, 2012-08, Vol.60 (8), p.738-746

2012

Volltextzugriff (PDF)

Severe Renal Impairment and Stroke Prevention in Atrial Fibrillation: Implications for Thromboprophylaxis and Bleeding Risk

Journal of the American College of Cardiology, 2011-03, Vol.57 (12), p.1339-1348

2011

Volltextzugriff (PDF)

Oral Anticoagulation and Antiplatelets in Atrial Fibrillation Patients After Myocardial Infarction and Coronary Intervention

Journal of the American College of Cardiology, 2013-09, Vol.62 (11), p.981-989

2013

Volltextzugriff (PDF)

Risk of stroke in male and female patients with atrial fibrillation in a nationwide cohort

Nature communications, 2024-08, Vol.15 (1), p.6728-8, Article 6728

2024

Volltextzugriff (PDF)

Diagnostic accuracy of digital technologies compared with 12-lead ECG in the diagnosis of atrial fibrillation in adults: A protocol for a systematic review

PloS one, 2024-05, Vol.19 (5), p.e0301729-e0301729

2024

Volltextzugriff (PDF)

The non-vitamin K antagonist oral anticoagulants (NOACs) and extremes of body weight—a systematic literature review

Clinical research in cardiology, 2017-08, Vol.106 (8), p.565-572

2017

Volltextzugriff (PDF)

Non-vitamin K antagonist oral anticoagulants and the treatment of venous thromboembolism in cancer patients: a semi systematic review and meta-analysis of safety and efficacy outcomes

PloS one, 2014-12, Vol.9 (12), p.e114445

2014

Volltextzugriff (PDF)

EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion

Europace (London, England), 2014-10, Vol.16 (10), p.1397-1416

2014

Volltextzugriff (PDF)

1 – 25 von 3.805

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(3.660)
Mit Volltextzugriff
(3.250)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

7 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(2.959)
Life Sciences & Biomedicine
(2.878)
Humans
(2.471)
Cardiovascular System & Cardiology
(1.834)
Atrial Fibrillation
(1.346)
Cardiac & Cardiovascular Systems
(1.338)
Female
(1.233)
Male
(1.203)
Risk Factors
(1.005)
Aged
(994)
Stroke
(878)
Middle Aged
(802)
Atrial Fibrillation - Drug Therapy
(673)
Cardiac Arrhythmia
(663)
Atrial Fibrillation - Complications
(626)
General & Internal Medicine
(590)
Peripheral Vascular Disease
(585)
Biological And Medical Sciences
(537)
Medical Sciences
(534)
Anticoagulants - Therapeutic Use
(530)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Europace
(173)
Journal Of The American College Of Cardiology
(148)
Thrombosis And Haemostasis
(148)
International Journal Of Cardiology
(144)
Stroke
(127)
European Heart Journal
(119)
Chest
(105)
The American Journal Of Cardiology
(87)
Circulation
(63)
Thrombosis Research
(63)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(65)
... seit 30 Tagen
(23)

Menü

Weitere Dienste

Einstellungen

Sodium-glucose cotransporter 2 inhibitors (SGLT2i) and cardiac arrhythmias: a systematic review and meta-analysis

Inflammation in Atrial Fibrillation

New Oral Anticoagulants in Elderly Adults: Evidence from a Meta-Analysis of Randomized Trials

Stroke prevention in atrial fibrillation: an Asian perspective

The Role of Monocytes in Angiogenesis and Atherosclerosis

Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited

Comparative Validation of a Novel Risk Score for Predicting Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation: The HAS-BLED (Hypertension, Abnormal Renal/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly, Drugs/Alcohol Concomitantly) Score

Stroke and Bleeding in Atrial Fibrillation with Chronic Kidney Disease

Lipids and atrial fibrillation: New insights into a paradox

Discontinuation risk comparison among 'real-world' newly anticoagulated atrial fibrillation patients: Apixaban, warfarin, dabigatran, or rivaroxaban

Invited review: hypertension and atrial fibrillation: epidemiology, pathophysiology, and implications for management

EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: definition, characterization, and clinical implication

Net Clinical Benefit of Antithrombotic Therapy in Patients With Atrial Fibrillation and Chronic Kidney Disease: A Nationwide Observational Cohort Study

Hypertension management in cardio-oncology

Underuse of Oral Anticoagulants in Atrial Fibrillation: A Systematic Review

Temporal trends of antithrombotic therapy for stroke prevention in Korean patients with non-valvular atrial fibrillation in the era of non-vitamin K antagonist oral anticoagulants: A nationwide population-based study

Causes of death of patients with non-valvular atrial fibrillation in Asians

Indirect Comparisons of New Oral Anticoagulant Drugs for Efficacy and Safety When Used for Stroke Prevention in Atrial Fibrillation

Severe Renal Impairment and Stroke Prevention in Atrial Fibrillation: Implications for Thromboprophylaxis and Bleeding Risk

Oral Anticoagulation and Antiplatelets in Atrial Fibrillation Patients After Myocardial Infarction and Coronary Intervention

Risk of stroke in male and female patients with atrial fibrillation in a nationwide cohort

Diagnostic accuracy of digital technologies compared with 12-lead ECG in the diagnosis of atrial fibrillation in adults: A protocol for a systematic review

The non-vitamin K antagonist oral anticoagulants (NOACs) and extremes of body weight—a systematic literature review

Non-vitamin K antagonist oral anticoagulants and the treatment of venous thromboembolism in cancer patients: a semi systematic review and meta-analysis of safety and efficacy outcomes

EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion

Suchergebnisse filtern